Lab chemical and life sciences company Sigma-Aldrich ‘s proposed acquisition by Germany’s Merck KGaA has secured antitrust clearance in Brazil. Sigma-Aldrich has obtained an unconditional approval from Brazil’s Council for Economic Defense, the final outstanding approval needed for the transaction.
The approval follows the recently received antitrust clearances from the competition authorities of Israel and South Korea. The clearance by CADE will be effective after a waiting period of 15 days. The deal was also cleared by the European Commission and Chinese Ministry of Commerce in Jun 2015.
The transaction is still subject to Sigma-Aldrich’s fulfillment of the commitments made to the EC following the latter’s conditional approval.
Full content: CNN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Orders Google to Open Android App Store Amid Antitrust Pressure
Oct 7, 2024 by
CPI
Federal Judge Greenlights FTC’s Antitrust Lawsuit Against Amazon, Tosses Some State Claims
Oct 7, 2024 by
CPI
Supreme Court Rejects Uber and Lyft’s Appeal in California Gig Worker Suits
Oct 7, 2024 by
CPI
Supreme Court Sidesteps 5-Hour Energy Pricing Case, Allowing Antitrust Claims to Proceed
Oct 7, 2024 by
CPI
Tempur Sealy and Mattress Firm Argue FTC Proceedings Are Unconstitutional in New Suit
Oct 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh